Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Hims & Hers Health Inc (NYSE: HIMS) closed at $26.20 in the last session, down -0.61% from day before closing price of $26.36. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 17.24 million shares were traded. HIMS stock price reached its highest trading level at $27.13 during the session, while it also had its lowest trading level at $25.3111.
Ratios:
We take a closer look at HIMS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.39 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.03. For the most recent quarter (mrq), Quick Ratio is recorded 1.82 and its Current Ratio is at 2.14. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $42.
On August 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $24.Needham initiated its Buy rating on August 22, 2024, with a $24 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 20 ’24 when Oluyemi Okupe bought 69,496 shares for $26.20 per share.
Chi Michael bought 7,500 shares of HIMS for $195,000 on Dec 19 ’24. On Dec 17 ’24, another insider, Chi Michael, who serves as the Chief Commercial Officer of the company, sold 25,550 shares for $32.20 each. As a result, the insider received 822,710 and left with 193,601 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 5724150272 and an Enterprise Value of 5481439744. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 60.61, and their Forward P/E ratio for the next fiscal year is 29.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.58 while its Price-to-Book (P/B) ratio in mrq is 12.97. Its current Enterprise Value per Revenue stands at 4.413 whereas that against EBITDA is 91.783.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $35.02, while it has fallen to a 52-week low of $8.09. The 50-Day Moving Average of the stock is 2.54%, while the 200-Day Moving Average is calculated to be 36.06%.
Shares Statistics:
According to the various share statistics, HIMS traded on average about 16.55M shares per day over the past 3-months and 14129610 shares per day over the past 10 days. A total of 209.44M shares are outstanding, with a floating share count of 177.41M. Insiders hold about 18.71% of the company’s shares, while institutions hold 56.00% stake in the company. Shares short for HIMS as of 1732838400 were 42622007 with a Short Ratio of 2.57, compared to 1730332800 on 33843786. Therefore, it implies a Short% of Shares Outstanding of 42622007 and a Short% of Float of 22.219998999999998.
